Common Contracts
2 similar Master Services Agreement for Services Related to Metreleptin contracts by Amryt Pharma PLC
1st AMENDMENTMaster Services Agreement for Services Related to Metreleptin • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
This 1st AMENDMENT (“Amendment”) is entered by and between Bristol-Myers Squibb Company (“BMS”) and Accredo Health Group, Inc. (“Company”) as of January 19, 2014 (the “Effective Date of this Amendment”).
1st AMENDMENTMaster Services Agreement for Services Related to Metreleptin • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
This 1st AMENDMENT (“Amendment”) is entered by and between Bristol-Myers Squibb Company (“BMS”) and Accredo Health Group, Inc. (“Company”) as of January 19, 2014 (the “Effective Date of this Amendment”).
